Healthcare Technology

Study Compares Three Robotic Systems for Colon Cancer Surgery, Finding Feasibility but Differences in Performance
A prospective study comparing Da Vinci Xi, Hugo™ RAS, and Versius® robotic platforms for colon cancer surgery found all were feasible but revealed differences in conversion rates, operating time, and instrument usage, highlighting the need for larger trials.

PhillComm Global Adds Personal Security Platform Bond and Mental Health AI Startup Klarify to Client Roster
PhillComm Global expands its portfolio with Bond, a preventative personal security platform, and Klarify, an AI operating system for mental health providers, addressing systemic challenges in personal safety and healthcare administration.

AI-Powered Wearables Poised to Revolutionize Patient Monitoring and Clinical Decisions
Advances in AI and edge computing are transforming health care wearables from data collectors into tools for real-time clinical insights, benefiting companies like Apple and potentially easing burdens on health care systems.

LataMed AI Corp. to Attend MEDICA 2026 in Germany as Part of Healthcare Technology Strategy
LataMed AI Corp. will attend MEDICA 2026 in Dusseldorf to evaluate technologies and build relationships for its digital healthcare platform in Latin America.

NeuroOne to Present New Trigeminal Nerve Ablation System and Drug Delivery Platform at ASSFN Meeting
NeuroOne Medical Technologies will showcase its recently FDA-cleared OneRF® Trigeminal Nerve Ablation System and provide updates on its investigational SEEG-Drug Delivery System at the 2026 ASSFN Biennial Meeting, highlighting advancements in neurological surgery.

Visory Health Promotes Two Executives to C-Suite Amid Rapid Expansion
Visory Health announces promotions of Alexandra Robertson to Chief Growth Officer and Brittney Tierce to Chief Technology Officer, signaling the company's focus on scaling access to affordable prescription drugs.

Cardio Diagnostics to Showcase AI-Powered Heart Risk Solutions at National Benefits Conferences
Cardio Diagnostics Holdings will exhibit at four national benefits conferences in June, presenting AI-driven tools to help employers and plan administrators reduce cardiovascular disease costs and improve workforce health.

Cardio Diagnostics CEO Outlines India Expansion and Medicare Progress in Podcast Interview
Cardio Diagnostics Holdings CEO Dr. Meesha Dogan discusses the company's growth strategy, including expansion into India and progress with Medicare reimbursement, highlighting the importance of precision medicine in cardiovascular disease prevention.

Datavault AI and Wellgistics Health Launch DelivMeds AI, a $4B Healthcare Platform
Datavault AI forms DelivMeds AI through a partnership with Wellgistics Health and strategic acquisitions, aiming to revolutionize healthcare delivery with AI, blockchain, and biometrics.

Datavault AI and Wellgistics Health Launch $4B DelivMeds AI Venture to Revolutionize Healthcare Delivery
Datavault AI and Wellgistics Health form DelivMeds AI, a healthcare platform valued at $4 billion, combining AI, blockchain, and biometric verification for nationwide data-driven healthcare delivery.

Datavault AI Licenses Technology to Wellgistics Health to Tackle PBM-Driven Drug Pricing Inefficiencies
Datavault AI Inc. has granted an exclusive patent license to Wellgistics Health for its PharmacyChain platform, aiming to reduce prescription drug costs by bypassing traditional pharmacy benefit managers.

American Heart Association Launches Initiative to Close Technology Gaps in Emergency Cardiac and Stroke Care
The American Heart Association, with support from T-Mobile, is launching an initiative to identify and close technology and communication gaps in emergency response for cardiac arrest, heart attack, and stroke across 13 U.S. cities.

Keona Health Quantifies Hidden Costs of Manual Triage with New ROI Guidance
Keona Health's new ROI guidance reveals the financial and operational impact of manual triage, highlighting how AI-assisted triage can reduce costs, improve accuracy, and mitigate systemic risks in healthcare patient access.

SS Innovations Reports Record Q1 Revenue, Driven by Robotic Surgery Growth
SS Innovations International reported a 117% increase in quarterly revenue to $11.1 million, driven by strong SSi Mantra installations and procedures, as the company pursues global expansion and FDA approval.

AI Voice Analysis for Intoxication Detection Gains Traction: MindBio Therapeutics Featured in BioMedWire Editorial
MindBio Therapeutics Corp. is highlighted in a BioMedWire editorial for its AI-driven voice analysis platform that detects real-time impairment, with implications for law enforcement, workplace safety, and healthcare.

SS Innovations Achieves 4,500-Mile Telesurgery Milestone at Australian Surgeons Congress
SS Innovations successfully performed a live telesurgery spanning over 4,500 miles using its SSi Mantra robotic system, highlighting the potential to democratize global access to surgical expertise.

AI System Detects Pancreatic Cancer Signs Three Years Before Diagnosis
Mayo Clinic researchers have developed an AI system that identifies early warning signs of pancreatic cancer up to three years before formal diagnosis, potentially enabling earlier intervention and improved outcomes.

AI-Powered Wearables Poised to Transform Healthcare with Actionable Insights
Advances in artificial intelligence are enabling wearable devices to provide clinicians with actionable insights, moving beyond data collection to drive meaningful healthcare improvements.

Lantern Pharma Unveils Multi-Agent AI and Computational Biology Tools for withZeta.ai Platform
Lantern Pharma announced the next phase of its withZeta.ai platform, including ZetaSwarm and ZetaOmics, which could accelerate oncology research and create a new revenue stream for the company.

HeartBeam Expands Concierge Cardiology Footprint with Atelier Health Agreement
HeartBeam Inc. has signed a commercial agreement with Beverly Hills-based Atelier Health, expanding its launch footprint into Southern California and completing its initial targeted markets for its cable-free 3D ECG technology.

Aclarion Expands Commercial Team Amid Triple-Digit Growth in Nociscan Utilization
Aclarion granted inducement stock options to its new Western U.S. Commercial Director as demand for its Nociscan platform surges, reflecting strong adoption of its AI-driven chronic low back pain diagnostic tool.

MindBio Therapeutics Develops Cross-Language AI Model for Intoxication Detection, Expanding Non-Invasive Safety Screening
MindBio Therapeutics has created a language-agnostic AI speech model that detects drug and alcohol intoxication across multiple languages, enabling scalable, non-invasive testing for high-volume safety screening in industries like mining, aviation, and construction.

SS Innovations Surpasses 10,500 Surgeries with SSi Mantra Robotic System, Signaling Growing Global Adoption
SS Innovations International announced that its SSi Mantra surgical robotic system has been used in over 10,500 procedures across 11 countries, highlighting the system's rapid adoption and potential to democratize robotic surgery.

Ventripoint to Showcase AI-Powered Cardiac Imaging at European Paediatric Cardiology Conference
Ventripoint will exhibit its VMS+ 4.0 technology at the AEPC annual meeting, highlighting its potential to improve lifelong care for congenital heart disease patients through accurate, MRI-equivalent assessments from echocardiograms.

Aquinas Senior Living Achieves 99.8% Resident Adoption of Teton AI Monitoring Across Pennsylvania Portfolio
Aquinas Senior Living has scaled Teton's AI-powered monitoring platform across its Pennsylvania communities, achieving near-universal resident adoption and integrating an E-call system to unify fall detection and assistance requests.

HeartBeam to Report Q1 2026 Results, Highlight Commercial Launch and AI Initiatives
HeartBeam will host its Q1 2026 earnings call on May 13, providing updates on its limited commercial launch for arrhythmia assessment, extended-wear patch development, heart attack detection, and AI programs.

Oncotelic Therapeutics Advances AI and Robotics Platform Toward Initial Commercial Deployment
Oncotelic Therapeutics reports progress on its proprietary AI platform and robotics integration, aiming to improve efficiency and compliance in pharmaceutical development and manufacturing.

MindBio Therapeutics Files Patents for AI Voice Intoxication Detection Technology
MindBio Therapeutics has filed patent applications for its AI-driven voice technology that detects drug and alcohol intoxication, with commercial kiosks for mining and aviation on track for delivery by Q2 2026.

HeartBeam Partners with Mount Sinai to Develop AI-Powered ECG Algorithms
HeartBeam Inc. collaborates with Mount Sinai to advance AI-driven ECG technology, aiming to enhance remote cardiac monitoring and chronic condition management.

AI System Achieves 100% Antibiotic Prescribing Accuracy in Clinical Trial
An AI-powered clinical decision support system called Ask Eolas eliminated antibiotic prescribing errors in a randomized controlled trial, offering a potential solution to the U.S. antibiotic crisis where inappropriate prescribing contributes to millions of resistant infections annually.